C. F. Hjorth, “Multi-drug resistance protein 2 (MRP2) expression, adjuvant tamoxifen therapy, and risk of breast cancer recurrence: a Danish population-based nested case-control study”, AO, vol. 58, no. 2, pp. 168–174, Feb. 2019.